China
Global LPs steer clear of China - Mergermarket Forum
Geopolitical uncertainty is making global institutional investors increasingly risk-off on Asian private equity – and on China in particular – at a time when overallocation issues are already restraining the pace of commitments to the asset class.
China's Pudu Tech raises another tranche of Series C funding
Pudu Tech, a China-based manufacturer of service robots, has raised a fourth tranche of Series C funding amounting to several hundred million renminbi (CNY 100m equates to USD 14m) from local investor Yuedu Capital.
Shunwei commits $29m to China expense management platform
Maycur, a China-based software-as-a-service (SaaS) provider specialising in corporate expense management, has raised CNY 200m(USD 29m in Series C funding from Shunwei Capital.
China autonomous driving player Mogo raises $84m
Mogo Auto, a Chinese autonomous driving solutions provider, has raised CNY 580m (USD 84m) in a Series C extension featuring Tencent Holdings.
Q&A: ShawKwei & Partners’ Kyle Shaw
Kyle Shaw, founder and managing partner of ShawKwei & Partners, on bright spots in industrial manufacturing and becoming more Southeast Asia-centric as supply chains reduce China exposure
IDG leads $59m Series A for China’s Taichu Biotech
Shanghai Taichu Biotechnology, a China-based outsourced drug developer focused on novel treatments, has raised a serious A of CNY 400m (USD59m) led by IDG Capital.
Matrix leads $73m Series C for China’s Semi-Tech
Matrix Partners China has led a CNY 500m (USD 72m) Series C for Semi-Tech, a China-based software provider to the semiconductor industry, at a post-money valuation of CNY6bn.
China's Energysingularity raises $58m
China-based nuclear fusion start-up Energysingularity has raised a pre-Series A round of CNY 400m (USD58m) from investors including new energy-focused venture capital firm Yunhe Partners and local gaming company miHoYo
China: Who’s investing?
Private equity investment in China remains in the doldrums yet local investors claim to see green shoots. Where, when, and how they engage with the market is likely to differ from previous cycles
China insurance tech player raises $43m
Shanghai Kingstar Winning Software, a digital risk control solution provider for insurers, has raised a Series C round of CNY300m (USD 43m) led by China Taiping Insurance Group.
China's DCL raises $578m for renminbi fund
DCL Investments, one of the first local private equity firms to focus on distressed assets in China, has raised CNY 4bn (USD 578m) for its latest renminbi-denominated fund.
Eight Roads leads $38m round for China biotech player Adcentrx
China and US-based biotech company Adcentrx has raised USD38m in an extended Series A round led by Eight Roads Ventures, with participation from F-Prime Capital, ABio-X, Delta Capital, and Trinity Innovation Fund.
Deal focus: CBC gets counterintuitive in China
CBC Group has helped multiple start-ups move from in-licensing to drug development to commercialisation. With China’s Hasten, it is navigating this tried-and-tested journey in reverse
Deal focus: Chamlion leaves its mark on 3D printing
The dental industry was one of few areas in which China’s army of 3D printing start-ups found sufficient addressable demand. Chamlion has risen to the top of the pile by virtue of a timely services pivot
V Fund backs China treasury management software player
V Fund Management, a Beijing-based PE firm founded by a group of former Goldman Sachs bankers, has led a Series C round amounting to hundreds of millions of renminbi for Sikulifang, a local software-as-a-service (SaaS) provider specialising in treasury...
China intelligent chassis supplier raises $58m
Global Technology, a China-based provider of intelligent chassis, has raised a Series C round of CNY 400m (USD 58m) from CICC Capital, Shenzhen Investment Holdings Capital, Qingyan Capital, and Huosen H&S.
CTC Capital leads $72m round for China substrates specialist
Chinese semiconductor industry investor CTC Capital has led a first tranche of Series A funding of more than CNY 500m (USD 72.5m) for AaltoSemi, a local manufacturer of chip packaging substrates.
GL Capital leads $290m investment in China’s Sangon Biotech
Chinese healthcare-focused private equity firm GL Capital has led a CNY2bn (USD 290m) investment in local life sciences company Sangon Biotech.
CBC, Mubadala lead $315m round for China's Hasten Biopharma
Specialist healthcare investor CBC Group and Mubadala Investment have led a USD 315m round for China-based Hasten Biopharmaceutic, with participation from other undisclosed institutional investors.
Matrix China pushes out final close on Fund VII
Matrix Partners China has sought a three-month extension to the deadline for closing its latest venture capital fund with a view to reaching the USD 1.6bn target.
China energy storage battery maker Rongke raises $145m
Legend Capital has led a CNY 1bn (USD 145m) Series B funding round for China-based energy storage battery developer Rongke Power.